Company / Cash & Equivalents
Nutex Health, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$185.6M
FY2025
5-year range
$22.0M / $185.6M
FY2021-FY2025
Trend
+356.6%
vs FY2024
Sector context
#191 of 328
Industrials
What the data says
Cash & Equivalents changed +357% YoY in FY2025, a notable deviation from the 9-year average annual change of +15140%.
Based on SEC 10-K filings.
$186M in FY2025 with a 5-year CAGR of +485.7%.
Improved from $22M to $186M over the past 2 years.
Industrials sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +75.6%
- 5-Year CAGR
- +485.7%
- 10-Year CAGR
- -
Sector benchmark
#191 of 328 in IndustrialsTop 58% of 328This company $185.6M Sector average $700.9M
▼
-73.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +485.7%, indicating consistent growth.
- In FY2025, cash & equivalents increased 356.6% year-over-year.
- Ranks #191 out of 328 companies in the Industrials sector.
- Lowest cash & equivalents in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $185.6M | +356.6% |
| FY2024 | $40.6M | +84.7% |
| FY2023 | $22.0M | -35.8% |
| FY2022 | $34.3M | -5.2% |
| FY2021 | $36.1M | +134014.2% |
| FY2020 | $26.9K | -97.5% |
| FY2019 | $1.1M | +793.3% |
| FY2018 | $119.3K | +1162.2% |
| FY2017 | $9.4K | -10.2% |
| FY2016 | $10.5K | -91.4% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026